I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and world-changing—that ...

Adolescents and young adults are increasingly using GLP-1 receptor agonists for weight management, raising concerns among ...

Unsurprisingly, political leaders have seized on the promise of these drugs, hoping they might offer a ‘silver bullet’ (or ...

In the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with ...

Some less expensive versions of popular weight loss drugs are no longer available to patients, after the Food & Drug ...

Discover a recent report that states that, although GLP-1 medicines are generally well tolerated, there have been cases of ...

A report from the human resources trade group SHRM, which just released its 2025 Benefits Survey—the most comprehensive ...

Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

"Employers have absorbed the majority of cost increases over the past four years, and they likely cannot continue to do so," ...

Data from 32 studies concluded that the impact of exercise is modest in terms of meaningful weight loss. Caloric restriction ...

While Novo Nordisk stock has underperformed since my Strong Buy rating four months ago, the long-term investment thesis ...